rss
Br J Ophthalmol 2002;86:1314-1315 doi:10.1136/bjo.86.11.1314
  • Letter

Importance of molecular testing in dominant optic atrophy

  1. N Patel1,
  2. A J Churchill1,
  3. C Toomes2,
  4. N J Marchbank2,
  5. C F Inglehearn2,
  6. N Foulds3,
  7. A Moosavi4,
  8. M Teimory4
  1. 1Bristol Eye Hospital, Lower Maudlin Street, Bristol BS1 2LX, UK
  2. 2Molecular Medicine Unit, University of Leeds, Leeds LS9 7TF, UK
  3. 3St George’s Hospital and School of Medicine, London SW17 4QX, UK
  4. 4West Sussex Eye Unit, Worthing and St Richard’s Hospital, West Sussex, BN112DF, UK
  1. Correspondence to: Dr Patel; drnish1975{at}yahoo.com
  • Accepted 1 May 2002

Juvenile onset dominant optic atrophy (DOA) is the most common inherited optic atrophy with a variable prevalence of between 1 in 10 000 (Denmark) and 1 in 50 000.1,2 The majority of cases have been shown to have mutations in the OPA1 gene on chromosome 3.3–5 Reduced visual acuity of insidious onset, temporal pallor of the optic disc, centrocaecal scotoma, and generalised dyschromatopsia are the key clinical features.6 Recent studies, however, have shown that penetrance within families is much lower than first realised and the assignment of status using clinical criteria alone can result …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.